Literature DB >> 22713473

Quantification of birefringence readily measures the level of muscle damage in zebrafish.

Joachim Berger1, Tamar Sztal, Peter D Currie.   

Abstract

Muscular dystrophies are a group of genetic disorders that progressively weaken and degenerate muscle. Many zebrafish models for human muscular dystrophies have been generated and analysed, including dystrophin-deficient zebrafish mutants dmd that model Duchenne Muscular Dystrophy. Under polarised light the zebrafish muscle can be detected as a bright area in an otherwise dark background. This light effect, called birefringence, results from the diffraction of polarised light through the pseudo-crystalline array of the muscle sarcomeres. Muscle damage, as seen in zebrafish models for muscular dystrophies, can readily be detected by a reduction in the birefringence. Therefore, birefringence is a very sensitive indicator of overall muscle integrity within larval zebrafish. Unbiased documentation of the birefringence followed by densitometric measurement enables the quantification of the birefringence of zebrafish larvae. Thereby, the overall level of muscle integrity can be detected, allowing the identification and categorisation of zebrafish muscle mutants. In addition, we propose that the establish protocol can be used to analyse treatments aimed at ameliorating dystrophic zebrafish models.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22713473     DOI: 10.1016/j.bbrc.2012.06.040

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Trent A Waugh; Eric Horstick; Junguk Hur; Samuel W Jackson; Ann E Davidson; Xingli Li; James J Dowling
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

2.  Macrophages provide a transient muscle stem cell niche via NAMPT secretion.

Authors:  Phong D Nguyen; Fernando J Rossello; Verena C Wimmer; Jean L Tan; Dhanushika Ratnayake; Laura A Galvis; Ziad Julier; Alasdair J Wood; Thomas Boudier; Abdulsalam I Isiaku; Silke Berger; Viola Oorschot; Carmen Sonntag; Kelly L Rogers; Christophe Marcelle; Graham J Lieschke; Mikaël M Martino; Jeroen Bakkers; Peter D Currie
Journal:  Nature       Date:  2021-02-10       Impact factor: 49.962

Review 3.  Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies.

Authors:  Elizabeth M Gibbs; Eric J Horstick; James J Dowling
Journal:  FEBS J       Date:  2013-07-25       Impact factor: 5.542

Review 4.  Porcine models of muscular dystrophy.

Authors:  Joshua T Selsby; Jason W Ross; Dan Nonneman; Katrin Hollinger
Journal:  ILAR J       Date:  2015

Review 5.  Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine.

Authors:  Nalinda B Wasala; Shi-Jie Chen; Dongsheng Duan
Journal:  Expert Opin Drug Discov       Date:  2020-01-30       Impact factor: 6.098

6.  Muscle dysfunction in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Jeffrey J Widrick; Matthew S Alexander; Benjamin Sanchez; Devin E Gibbs; Genri Kawahara; Alan H Beggs; Louis M Kunkel
Journal:  Physiol Genomics       Date:  2016-10-07       Impact factor: 3.107

Review 7.  Recent advances using zebrafish animal models for muscle disease drug discovery.

Authors:  Lisa Maves
Journal:  Expert Opin Drug Discov       Date:  2014-06-14       Impact factor: 6.098

8.  Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling.

Authors:  Genri Kawahara; Molly J Gasperini; Jennifer A Myers; Jeffrey J Widrick; Alal Eran; Peter R Serafini; Matthew S Alexander; Mathew T Pletcher; Carl A Morris; Louis M Kunkel
Journal:  Hum Mol Genet       Date:  2013-11-13       Impact factor: 6.150

9.  DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies.

Authors:  Andrea L Reid; Yimin Wang; Adrienne Samani; Rylie M Hightower; Michael A Lopez; Shawn R Gilbert; Lara Ianov; David K Crossman; Louis J Dell'Italia; Douglas P Millay; Thomas van Groen; Ganesh V Halade; Matthew S Alexander
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

10.  Immobilization of Dystrophin and Laminin α2-Chain Deficient Zebrafish Larvae In Vivo Prevents the Development of Muscular Dystrophy.

Authors:  Mei Li; Anders Arner
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.